ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Use this ATAI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ATAI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ATAI SEC filings page. Lician reads the product cache first so this HTML stays unique to ATAI Life Sciences BV even when a live quote feed is slow.
Latest cached year on this hub. Full ATAI income, balance, and cash tables.